Key result
Variants in HLA-DRB1 link to ~55% higher odds of pediatric IgA vasculitis.
Case-Control (n=8,098)
Answers are grounded in this paper and cite their sources.
Genome-wide studies identified novel genetic mechanisms and risk loci for IgA vasculitis, including FCAR and INPP5D, highlighting the role of myeloid cells and FcαR signaling.
IgA vasculitis (IgAV) is a pediatric disease with skin and systemic manifestations. Here, we conducted genome, transcriptome, and proteome-wide association studies in 2,170 IgAV cases and 5,928 controls, generated IgAV-specific maps of gene expression and splicing from blood of 255 pediatric cases, and reconstructed myeloid-specific regulatory networks to define disease master regulators modulated by the newly identified disease driver genes. We observed significant association at the HLA - DRB1 (OR=1.55, P=1.1×10 −25 ) and fine-mapped specific amino-acid risk substitutions in DRβ1. We discovered two novel non-HLA loci: FCAR (OR=1.51, P=1.0×10 −20 ) encoding a myeloid IgA receptor FcαR, and INPP5D (OR=1.34, P=2.2×10 −09 ) encoding a known inhibitor of FcαR signaling. The FCAR risk locus co-localized with a cis-eQTL increasing FCAR expression; the risk alleles disrupted a PRDM1 binding motif within a myeloid enhancer of FCAR . Another risk locus was associated with a higher genetically predicted levels of plasma IL6R. The IL6R risk haplotype carried a missense variant contributing to accelerated cleavage of IL6R into a soluble form. Using systems biology approaches, we prioritized IgAV master regulators co-modulated by FCAR , INPP5D and IL6R in myeloid cells. We additionally identified 21 shared loci in a cross-phenotype analysis of IgAV with IgA nephropathy, including novel loci PAID4, WLS , and ANKRD55 .
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) conducted a case-control in IgA vasculitis (n=8,098). Genetic variants (HLA-DRB1, FCAR, INPP5D) vs. Controls without IgA vasculitis was evaluated on Association with IgA vasculitis (OR 1.55, p=1.1×10−25). Genetic variants in HLA-DRB1, FCAR, and INPP5D were associated with pediatric IgA vasculitis.